RAPT Therapeutics

IPO

Relentlessly focused on advancing treatments for patients with inflammatory and immunologic diseases

Public · San Francisco, United States · Founded 2015 · $497.0M raised

Employees
51–200
Founded
2015
Business Model
B2B
Website
rapt.com
Total Funding
$497.0M
Last Round
$250.0M Private EquityOct 2025
Rounds
4
Type
Public

About

RAPT Therapeutics is a clinical-stage biopharmaceutical company focused on discovering, developing, and commercializing oral small molecule therapeutics that target key drivers of the immune system for inflammatory and immunologic diseases, including food allergy.

Summary

RAPT Therapeutics is a Biotech company based in San Francisco, United States, founded in 2015. It has raised $497.0M in total across 4 rounds, most recently a $250.0M Private Equity round in Oct 2025. Investors include GV.

Tech & App Stack

5 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Private EquityPrivate EquityOct 2025
$250.0M

Sign up to see all 7 rounds

Series C through Private Equity — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

RAPT Therapeutics on Indexed.vc
<a href="https://indexed.vc/companies/rapt-therapeutics"><img src="https://indexed.vc/api/badge/company/rapt-therapeutics" alt="RAPT Therapeutics on Indexed.vc" width="260" height="76" /></a>